Buy & Sell Bundamedik Tbk - BMHS Share Price Today
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q3
’24
Q4
’24
Q1
’25
Q2
’25
Q3
’25
| Item | Q3 2025 | Y/Y Change |
| Revenue | Rp1.15T | -0.18% |
| Cost of Revenue | Rp616.57B | +0.79% |
| Gross Profit | Rp538.32B | -1.26% |
| General Expenses, Depreciation, Interest | Rp468.75B | -0.75% |
| Operating Profit | Rp69.57B | -4.58% |
| Other Income | -Rp43.43B | -7.64% |
| EBT | Rp26.13B | +0.99% |
| Taxes | -Rp6.12B | -207.36% |
| Net Income | Rp12.25B | +3.85% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q3
’24
Q4
’24
Q1
’25
Q2
’25
Q3
’25
| Item | Q3 2025 | Y/Y Change |
| Total Assets | Rp3.64T | -3.67% |
| Total Liabilities | Rp1.48T | -8.46% |
| Total Equity | Rp1.72T | +7.6% |
| Total Liabilities & Total Equity | Rp3.2T | -0.48% |
Cash Flow
Operating
Investing
Finance
Net CF
Q3
’24
Q4
’24
Q1
’25
Q2
’25
Q3
’25
| Item | Q3 2025 | Y/Y Change |
| CF from Operations | Rp50.98B | +47.31% |
| CF from Investment | Rp102.53B | -49.06% |
| CF from Financing | Rp78.9B | -88.68% |
| Net Cash Flow | Rp27.35B | -94.84% |